140 related articles for article (PubMed ID: 28944739)
1. Drug delivery for tuberculosis: is inhaled therapy the key to success?
Traini D; Young PM
Ther Deliv; 2017 Oct; 8(10):819-821. PubMed ID: 28944739
[No Abstract] [Full Text] [Related]
2. Particulate pulmonary delivery systems containing anti-tuberculosis agents.
Gupta A; Pandya SM; Mohammad I; Agrawal AK; Mohan M; Misra A
Crit Rev Ther Drug Carrier Syst; 2013; 30(4):277-91. PubMed ID: 23662603
[TBL] [Abstract][Full Text] [Related]
3. Current Approaches and Future Prospects of Nanomedicine in Tuberculosis Therapy.
Athar MT; Ullah Z
Recent Pat Antiinfect Drug Discov; 2017; 12(2):120-127. PubMed ID: 28443511
[TBL] [Abstract][Full Text] [Related]
4. Inhaled drug therapy for treatment of tuberculosis.
Misra A; Hickey AJ; Rossi C; Borchard G; Terada H; Makino K; Fourie PB; Colombo P
Tuberculosis (Edinb); 2011 Jan; 91(1):71-81. PubMed ID: 20875771
[TBL] [Abstract][Full Text] [Related]
5. The long and winding road to inhaled TB therapy: not only the bug's fault.
Giovagnoli S; Schoubben A; Ricci M
Drug Dev Ind Pharm; 2017 Mar; 43(3):347-363. PubMed ID: 27977937
[TBL] [Abstract][Full Text] [Related]
6. Optimisation of inhaled tuberculosis therapies and implications for host-pathogen interactions.
Hickey AJ; Misra A; Robertson BD
Tuberculosis (Edinb); 2011 Jan; 91(1):64. PubMed ID: 21112251
[No Abstract] [Full Text] [Related]
7. Inhaled therapies for tuberculosis and the relevance of activation of lung macrophages by particulate drug-delivery systems.
Verma RK; Singh AK; Mohan M; Agrawal AK; Misra A
Ther Deliv; 2011 Jun; 2(6):753-68. PubMed ID: 22822507
[TBL] [Abstract][Full Text] [Related]
8. Oral therapy using nanoparticle-encapsulated antituberculosis drugs in guinea pigs infected with Mycobacterium tuberculosis.
Johnson CM; Pandey R; Sharma S; Khuller GK; Basaraba RJ; Orme IM; Lenaerts AJ
Antimicrob Agents Chemother; 2005 Oct; 49(10):4335-8. PubMed ID: 16189115
[TBL] [Abstract][Full Text] [Related]
9. Fighting tuberculosis: old drugs, new formulations.
Blasi P; Schoubben A; Giovagnoli S; Rossi C; Ricci M
Expert Opin Drug Deliv; 2009 Sep; 6(9):977-93. PubMed ID: 19678791
[TBL] [Abstract][Full Text] [Related]
10. Antitubercular inhaled therapy: opportunities, progress and challenges.
Pandey R; Khuller GK
J Antimicrob Chemother; 2005 Apr; 55(4):430-5. PubMed ID: 15761077
[TBL] [Abstract][Full Text] [Related]
11. Inhaled drug treatment for tuberculosis: Past progress and future prospects.
Hickey AJ; Durham PG; Dharmadhikari A; Nardell EA
J Control Release; 2016 Oct; 240():127-134. PubMed ID: 26596254
[TBL] [Abstract][Full Text] [Related]
12. Liposomes as drug delivery systems for the treatment of TB.
Pinheiro M; Lúcio M; Lima JL; Reis S
Nanomedicine (Lond); 2011 Oct; 6(8):1413-28. PubMed ID: 22026379
[TBL] [Abstract][Full Text] [Related]
13. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
[TBL] [Abstract][Full Text] [Related]
14. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
Garg T; Goyal AK; Rath G; Murthy RS
Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961
[TBL] [Abstract][Full Text] [Related]
15. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
Gelperina S; Kisich K; Iseman MD; Heifets L
Am J Respir Crit Care Med; 2005 Dec; 172(12):1487-90. PubMed ID: 16151040
[TBL] [Abstract][Full Text] [Related]
16. Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis.
Maretti E; Rossi T; Bondi M; Croce MA; Hanuskova M; Leo E; Sacchetti F; Iannuccelli V
Int J Pharm; 2014 Feb; 462(1-2):74-82. PubMed ID: 24374224
[TBL] [Abstract][Full Text] [Related]
17. The magic bullets and tuberculosis drug targets.
Zhang Y
Annu Rev Pharmacol Toxicol; 2005; 45():529-64. PubMed ID: 15822188
[TBL] [Abstract][Full Text] [Related]
18. Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery.
Miranda MS; Rodrigues MT; Domingues RMA; Torrado E; Reis RL; Pedrosa J; Gomes ME
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():1090-1103. PubMed ID: 30274040
[TBL] [Abstract][Full Text] [Related]
19. Nanoemulsion for the Effective Treatment and Management of Anti-tubercular Drug Therapy.
Beg S; Saini S; Imam SS; Rahman M; Swain S; Hasnain MS
Recent Pat Antiinfect Drug Discov; 2017; 12(2):85-94. PubMed ID: 28480833
[TBL] [Abstract][Full Text] [Related]
20. Sustained release drug delivery systems in management of tuberculosis.
Khuller GK; Pandey R
Indian J Chest Dis Allied Sci; 2003; 45(4):229-30. PubMed ID: 12962455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
